• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测I型胃神经内分泌肿瘤复发的因素:一项单中心研究

Factors Predicting Type I Gastric Neuroendocrine Neoplasia Recurrence: A Single-Center Study.

作者信息

Sheikh-Ahmad Mohammad, Saiegh Leonard, Shalata Anan, Bejar Jacob, Kreizman-Shefer Hila, Sirhan Majd F, Matter Ibrahim, Swaid Forat, Laniado Monica, Mubariki Nama, Rainis Tova, Rosenblatt Ilana, Yovanovich Ekaterina, Agbarya Abed

机构信息

Institute of Endocrinology, Bnai Zion Medical Center, 47 Golomb St., Haifa 31048, Israel.

The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel.

出版信息

Biomedicines. 2023 Mar 9;11(3):828. doi: 10.3390/biomedicines11030828.

DOI:10.3390/biomedicines11030828
PMID:36979807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10045191/
Abstract

Type I gastric neuroendocrine neoplasms (gNENs) are associated with atrophic gastritis and have a high recurrence rate, which means frequent endoscopies are required. The objective of this study was to identify factors predicting the local recurrence of type I gNENs. The clinical course and the pathological and biochemical data of patients with type I gNENs treated at Bnai Zion Medical Center between 2006 and 2022 were analyzed retrospectively. Twenty-seven type I gNENs were evaluated. The follow-up period was 41 months (range: 11-288 months). Recurrence of the tumor occurred in 13/27 (48%) patients after 35 months (median (M), interquartile range (IQR): 21-67.5). Serum gastrin levels were significantly higher in patients with recurrent disease versus patients with non-recurrent disease (788 vs. 394 ng/L; = 0.047), while the Ki-67 index was significantly lower in patients with recurrent disease versus patients with non-recurrent disease (1% vs. 3.5%; = 0.035). Tumor size, mitotic count, and serum chromogranin A levels did not correlate with recurrence. The present study emphasizes the role of gastrin in the pathogenesis of gNEN recurrence and highlights the debate regarding the ability of the Ki-67 index to predict the clinical course of this disease.

摘要

I型胃神经内分泌肿瘤(gNENs)与萎缩性胃炎相关,且复发率高,这意味着需要频繁进行内镜检查。本研究的目的是确定预测I型gNENs局部复发的因素。回顾性分析了2006年至2022年在贝纳伊锡安医疗中心接受治疗的I型gNENs患者的临床病程以及病理和生化数据。对27例I型gNENs进行了评估。随访期为41个月(范围:11 - 288个月)。13/27(48%)例患者在35个月后(中位数(M),四分位间距(IQR):21 - 67.5)出现肿瘤复发。复发患者的血清胃泌素水平显著高于未复发患者(788 vs. 394 ng/L;P = 0.047),而复发患者的Ki-67指数显著低于未复发患者(1% vs. 3.5%;P = 0.035)。肿瘤大小、有丝分裂计数和血清嗜铬粒蛋白A水平与复发无关。本研究强调了胃泌素在gNEN复发发病机制中的作用,并突出了关于Ki-67指数预测该疾病临床病程能力的争议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4368/10045191/6d6eb5ea3be7/biomedicines-11-00828-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4368/10045191/9749ed8d695c/biomedicines-11-00828-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4368/10045191/6d6eb5ea3be7/biomedicines-11-00828-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4368/10045191/9749ed8d695c/biomedicines-11-00828-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4368/10045191/6d6eb5ea3be7/biomedicines-11-00828-g002.jpg

相似文献

1
Factors Predicting Type I Gastric Neuroendocrine Neoplasia Recurrence: A Single-Center Study.预测I型胃神经内分泌肿瘤复发的因素:一项单中心研究
Biomedicines. 2023 Mar 9;11(3):828. doi: 10.3390/biomedicines11030828.
2
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis.慢性萎缩性自身免疫性胃炎患者胃神经内分泌肿瘤的发病率和患病率
World J Gastrointest Oncol. 2023 Aug 15;15(8):1451-1460. doi: 10.4251/wjgo.v15.i8.1451.
3
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.慢性萎缩性胃炎患者1型胃神经内分泌肿瘤的危险因素。一项回顾性多中心研究。
Endocrine. 2017 Jun;56(3):633-638. doi: 10.1007/s12020-016-1099-y. Epub 2016 Sep 3.
4
[Establishment of risk model for predicting the progression within 1 year of patients with gastric neuroendocrine neoplasms and its value of prediction].[胃神经内分泌肿瘤患者1年内进展预测风险模型的建立及其预测价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Nov 25;19(11):1247-1251.
5
Gastric neuroendocrine neoplasm with late liver metastasis.胃神经内分泌肿瘤伴晚期肝转移
Endocrinol Diabetes Metab Case Rep. 2018 Aug 3;2018. doi: 10.1530/EDM-18-0048. eCollection 2018.
6
Clinicopathological features of primary gastric neuroendocrine neoplasms: A single-center analysis.原发性胃神经内分泌肿瘤的临床病理特征:单中心分析
J Dig Dis. 2016 Mar;17(3):162-8. doi: 10.1111/1751-2980.12326.
7
Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study.肿瘤类型和大小是胃神经内分泌肿瘤的预后因素:一项多中心回顾性研究。
Dig Liver Dis. 2019 Oct;51(10):1456-1460. doi: 10.1016/j.dld.2019.04.016. Epub 2019 Jun 5.
8
Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis.在慢性自身免疫性萎缩性胃炎患者中,使用生长抑素类似物间歇性治疗复发性1型胃类癌。
Dig Liver Dis. 2015 Nov;47(11):978-83. doi: 10.1016/j.dld.2015.07.155. Epub 2015 Aug 8.
9
Selective Resection of Type 1 Gastric Neuroendocrine Neoplasms and the Risk of Progression in an Endoscopic Surveillance Programme.1 型胃神经内分泌肿瘤的选择性切除术和内镜监测计划中进展的风险。
Dig Surg. 2021;38(1):38-45. doi: 10.1159/000510962. Epub 2020 Dec 1.
10
Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.散发性胃高分化神经内分泌肿瘤具有较高的Ki-67增殖指数。
Endocr Pathol. 2016 Sep;27(3):259-67. doi: 10.1007/s12022-016-9443-6.

引用本文的文献

1
Last decade of advances in gastric neuroendocrine tumors: Innovations, challenges, and future directions.胃神经内分泌肿瘤近十年的进展:创新、挑战与未来方向
World J Clin Oncol. 2025 May 24;16(5):104577. doi: 10.5306/wjco.v16.i5.104577.
2
Clinical Characteristics and Long-term Outcomes of Gastric Neuroendocrine Tumors.胃神经内分泌肿瘤的临床特征与长期预后
Gut Liver. 2025 Mar 15;19(2):189-197. doi: 10.5009/gnl240272. Epub 2025 Jan 3.
3
Neuroendocrine Neoplasia: From Pathophysiology to Novel Therapeutic Approaches.神经内分泌肿瘤:从病理生理学到新型治疗方法

本文引用的文献

1
New Developments in Gastric Neuroendocrine Neoplasms.胃神经内分泌肿瘤的新进展。
Curr Oncol Rep. 2022 Jan;24(1):77-88. doi: 10.1007/s11912-021-01175-y. Epub 2022 Jan 20.
2
Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study.1 型胃神经内分泌肿瘤的处理:一项 10 年单中心前瞻性研究。
Dig Liver Dis. 2022 Jul;54(7):890-895. doi: 10.1016/j.dld.2021.11.012. Epub 2021 Dec 10.
3
Gastric neuroendocrine neoplasms: A review.胃神经内分泌肿瘤:综述
Biomedicines. 2024 Apr 4;12(4):801. doi: 10.3390/biomedicines12040801.
4
Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study.1 型胃神经内分泌肿瘤的治疗:一项 11 年回顾性单中心研究。
BMC Gastroenterol. 2023 Dec 14;23(1):440. doi: 10.1186/s12876-023-03079-6.
5
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis.慢性萎缩性自身免疫性胃炎患者胃神经内分泌肿瘤的发病率和患病率
World J Gastrointest Oncol. 2023 Aug 15;15(8):1451-1460. doi: 10.4251/wjgo.v15.i8.1451.
World J Clin Cases. 2021 Sep 26;9(27):7973-7985. doi: 10.12998/wjcc.v9.i27.7973.
4
Gastric Neuroendocrine Tumors: Reappraisal of Type in Predicting Outcome.胃神经内分泌肿瘤:对预测预后类型的重新评估。
Ann Surg Oncol. 2021 Dec;28(13):8838-8846. doi: 10.1245/s10434-021-10293-7. Epub 2021 Jun 13.
5
Clinical Outcomes of Endoscopic Treatment for Type 1 Gastric Neuroendocrine Tumor.内镜治疗 1 型胃神经内分泌肿瘤的临床疗效。
J Gastrointest Surg. 2021 Oct;25(10):2495-2502. doi: 10.1007/s11605-021-04997-0. Epub 2021 Apr 6.
6
Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.长期使用质子泵抑制剂的患者发生的胃神经内分泌肿瘤为惰性肿瘤,预后良好。
Histopathology. 2020 Dec;77(6):865-876. doi: 10.1111/his.14220. Epub 2020 Sep 20.
7
Improving the accuracy of gastrointestinal neuroendocrine tumor grading with deep learning.深度学习提高胃肠道神经内分泌肿瘤分级准确性。
Sci Rep. 2020 Jul 6;10(1):11064. doi: 10.1038/s41598-020-67880-z.
8
Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours.系统评价:局限性低级别上消化道神经内分泌肿瘤的治疗。
Aliment Pharmacol Ther. 2020 Jun;51(12):1247-1267. doi: 10.1111/apt.15765. Epub 2020 May 11.
9
Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research.胃神经内分泌肿瘤发病和预后趋势:基于 SEER 和多中心研究的一项研究。
Gastric Cancer. 2020 Jul;23(4):591-599. doi: 10.1007/s10120-020-01046-8. Epub 2020 Feb 5.
10
Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.胃神经内分泌肿瘤 1 型:系统评价和荟萃分析。
World J Gastroenterol. 2019 Sep 21;25(35):5376-5387. doi: 10.3748/wjg.v25.i35.5376.